Trials and Therapy Archives

Home › Thrombosis and cancer › Trials and Therapy

Isolated Distal DVT In Cancer Patients: What Do Recent Studies Suggest?

In a recent issue of the Journal of Thrombosis and Hemostasis, we report that cancer patients with isolated distal deep...

Cancer-associated venous thromboembolism (VTE) is known to impact up to one-fifth of patients with cancer. The...

The American Society of Clinical Oncology just published the new recommendations regarding VTE prophylaxis and...

Approximately 4% of cancer patients have non-valvular atrial fibrillation (NVAF) and require anticoagulation for...

Since the publication of the SELECT-D trial1 and the Hokusai-VTE Cancer study2, there has been a shift in the...

Introduction Once considered a condition of adults or the elderly, venous thromboembolism (VTE) is now being recognized...

Patients with primary and metastatic brain tumors have a high risk of venous thromboembolism (VTE), occurring in 20-30%...

A year after the results of the CANTOS trial were first presented, they were still an important talking point at ESC...

The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a...

Rapping about new anticoagulants for CAT at ICTHIC 2018 Cancer patients are four or five times as likely to develop...